growth continues, page-3

Ventracor Growth Continues – 10 Active US Centres
SYDNEY Australia 20 November 2007: Ventracor (ASX:VCR) today announced 10 US
hospitals have implanted at least one VentrAssist™ as part of its US clinical trials, and that
more centres are trained and awaiting availability of patients.
Since the Annual General Meeting on 24 October, there have been 14 implants of the
VentrAssist left ventricular assist device (LVAD) worldwide.
There have now been 172 implants at 24 hospitals worldwide, with over 83 years of cumulative
patient experience. The VentrAssist implantable blood pump is designed for long term use, and
the longest duration implant is now over three years.
In the USA, 18 patients have been implanted as part of the Company’s US Bridge-to-Transplant
(BTT) Pivotal Trial, which involves approximately 140 patients. The trial aims to evaluate the
safety and efficacy of the VentrAssist for short term use in patients whose heart deteriorates
before a donor heart is available for transplant.
Eight patients have been enrolled in the US Destination Therapy (DT) Trial out of approximately
225 enrolments for the trial. The randomized trial is designed to evaluate the safety and efficacy
of long-term use of the VentrAssist in patients with heart failure who are not candidates for a
heart transplant.
In Australia, three patients have recently been implanted with the new version VentrAssist
LVA4 under the Special Access Scheme (SAS). The new version features several
enhancements introduced in response to physician feedback. VentrAssist LVA4 will be
introduced in all markets as soon as approval is obtained in response to the regulatory
submissions already made.
Next week, Ventracor Chief Executive Officer Peter Crosby will present at the 19th Annual
Piper Jaffray Global Health Care Conference on Tuesday 27 November in New York City.
Mr Crosby will speak at 12:30pm (US Eastern Time) and the presentation will be followed by a
question and answer session. A link to the live webcast and copy of the presentation can be
viewed at www.ventracor.com or http://www.piperjaffray.com/conferences on the day.